| Literature DB >> 35658853 |
Eduardo Cezar Santos1, Stefânia Prebianchi2, Ingrid Nayara Santos3, Mariana Neri Kurihara3, Adriana Dell'Aquila4, Carlos Finelli2, Fernando Baldy Dos Reis2, Mauro José Salles3,4,5.
Abstract
BACKGROUND: Little is known about the role of COVID-19 pandemic period on the epidemiology of fracture-related infection (FRI). The present study summarizes the changes in the prevalence, microbiology, and risk factors of FRI during this period.Entities:
Keywords: COVID-19 pandemic; Cancer; Elderly; Fracture-related infection; Gram-negative bacteria; Multidrug-resistance; Prior use of antibiotic; Risk factors
Mesh:
Substances:
Year: 2022 PMID: 35658853 PMCID: PMC9166157 DOI: 10.1186/s12891-022-05493-5
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.562
Fig. 1Diagram of patients involved in the study
Demographic and clinical characteristics associated with trauma and treatment of 132 patients evaluated
| Variables | Results N(%) |
|---|---|
| Male | 99 (75) |
| Mean ± Standard Deviation | 50.4 ± 22.9 |
| P50 (P25 – P75) | 44.0 (31.0; 70.7) |
| up to 21 years old | 11 (8.3) |
| From 22 to 40 years old | 44 (33.3) |
| From 41 to 60 years old | 31 (23.5) |
| > 60 years old | 46 (34.9) |
| Arterial Hypertension | 30 (22.7) |
| Diabetes Mellitus | 15 (11.3) |
| Renal KidneyDisease | 6 (4.5) |
| Cancer | 4 (3.0) |
| Others comorbidities | 13 (9.8) |
| 1 | 97 (73.5) |
| ≥ 2 | 35 (16.5) |
| Yes | 5 (3.8) |
| Up to 4 | 106 (80.9) |
| Over 4 | 25 (19.1) |
| Up to 24 h | 51 (38.7) |
| From 25 to 72 h | 37 (28.0) |
| Over 72 h | 44 (33.3%) |
| Open fracture | 36 (27.3) |
| Closed fracture | 96 (72.7) |
| Type I-II | 11 (30.6) |
| III A, B and C | 25 (69.4) |
| Plate/Screw | 58 (43.9) |
| intramedullary nail | 74 (56.1) |
| Yes | 37 (50.0) |
| Lower | 106 (80.3) |
| Upper | 23 (17.4) |
| Lower / Upper | 3 (2.3) |
| Yes | 27 (20.6) |
| Motorcycle / car accident | 56 (42.4) |
| Fall from one's own height | 40 (30.3) |
| Fall from height | 19 (14.4) |
| Others | 17 (12.9) |
| Yes | 5 (3.8) |
a—one undisclosed patient, ASAb—American Society of Anesthesiologists
Risk factor for the infection outcome according to univariate analysis
| Analyzed variable | Not Infected ( | Infected ( | |
|---|---|---|---|
| N (%) | N (%) | ||
| Male | 84 (75.8) | 15 (71.43) | 0.680* |
| Age (average-years) | 50.8 | 48.5 | 0.651** |
| P50(p25-p75) | 44.0 (31.0; 72.0) | 48.0 (30.5; 64.0) | |
| Habit of smoking | 30 (27.0) | 5 (23.8) | 0.759 |
| Alcoholism | 29 (26.1) | 4 (19.0) | 0.492* |
| Arterial hypertension | 23 (20.7) | 7 (33.3) | 0.255*** |
| Cancer | 3 (2.7) | 2 (9.5) | 0.179*** |
| Classification ASAb | |||
| 1 | 83 (74.7) | 14 (66.6) | 0.440* |
| ≥ 2 | 28 (25.2) | 7 (33.3) | |
| Charlson indexa | |||
| Up to 4 | 88 (79.2) | 18 (85.7) | 0.763*** |
| Over 4 | 22 (19.8) | 3 (14.2) | |
| Mechanism of injury | |||
| Fall from one's own height | 38 (3.4) | 2 (9.5) | |
| Motorbike/car accident | 47 (42.3) | 9 (42.8) | 0.023*** |
| Fall from height | 4 (3.6) | 3 (14.2) | |
| Open fracture | 23 (20.7) | 13(61.9) | < 0.001* |
| Closed fracture | 88 (91.7) | 8 (8.3) | |
| Gustilo-Anderson | |||
| I | 4 (3.6) | 2 (9.5) | |
| II | 4 (3.6) | 1 (4.7) | 0.688* |
| III A, B and C | 15 (13.5) | 10 (47.6) | |
| External fixatora | 18 (16.2) | 9 (42.8) | 0.015*** |
| Low Limber fracture | 88 (79.2) | 18 (85.7) | 0.861*** |
| Time interval Fracture-surgery(h) | 87.8 ± 119.8 | 93.3 ± 118,8 | 0.847** |
| Average p50 (p25 – p75) | 48 (24; 96) | 24 (12; 121.5) | |
| Type of osteosynthesis | |||
| Plate and screw | 43 (38.7) | 15 (71.4) | 0.006* |
| Locked intramedullary nail (IMN) | 68 (61.2) | 6 (28.5) | |
| Recent preoperative use of ATB | 1 (0.9) | 4 (19.0) | 0.002*** |
| Infection by covid | 2 (1.8) | 3 (14.2) | 0,028*** |
The probability of significance refers to the Chi-square test (*), Student's t test (**), Fisher's exact test (***), a—one undisclosed patient, ASAb American Society of Anesthesiologists, ATB Antibiotic
Risk factors independently associated to infection outcome–multivariable analysis
| Analyzed Variable | PR (95% IC) | |
|---|---|---|
| Recent preoperative use of ATB | 7.0 (2,2; 22.4) | 0.001 |
| Cancer | 9.8 (2; 48.8) | 0.005 |
Significance probabilities in multivariable analysis refers to Poisson regression, PR prevalence ratio, ATB – antibiotics
Fig. 2Kaplan–Meier survival curve for infection considering recent preoperative use of ATB. DATABASE: 130 cases (No 125 cases and Yes 5 cases); ATB Antibiotic